Neonatal liver abscesses due to Candida infection effectively treated with caspofungin

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 5, 2009, Pages 906-909

  Filippi, Luca ^a   Poggi, Chiara ^a   Gozzini, Elena ^a   Meleleo, Rosanna ^a   Mirabile, Lorenzo ^a   Fiorini, Patrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Abscess; Candida infection; Neonatal infection; Neonatal sepsis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; CASPOFUNGIN; FLUCONAZOLE; GENTAMICIN;

ANAMNESIS; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; INFANT; INTESTINE ATRESIA; INTESTINE OBSTRUCTION; LABORATORY TEST; LIVER ABSCESS; LIVER FUNCTION TEST; MALE; NEWBORN; NEWBORN SEPSIS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND;

EID: 64149113478     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.01204.x     Document Type: Article

References (12)

1. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, et al. Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002 347 : 2020 9.
2. Johnsson H, Ewald U. The rate of candidaemia in preterm infants born at a gestational age of 23-28 weeks is inversely correlated to gestational age. Acta Paediatr 2004 93 : 954 8.
3. Benjamin DK Jr., Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006 117 : 84 92.
4. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr., National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006 118 : 717 22.
5. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, et al. National Epidemiology of Mycoses Survey (NEMIS) Study Group. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001 33 : 177 86.
6. Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Bedard M. Experience with caspofungin in the treatment of persistent fungemia in neonates. J Perinatol 2005 25 : 770 7.
7. Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Alfaro B, et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J 2004 23 : 1093 7.
8. Belet N, Ciftçi E, Ince E, Dalgiç N, Oncel S, Güriz H, et al. Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica. Scand J Infect Dis 2006 38 : 559 62.
9. Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 2006 117 : 1680 7.
10. Lam HS, Li AM, Chu WC, Yeung CK, Fok TF, Ng PC. Mal-positioned umbilical venous catheter causing liver abscess in a preterm infant. Biol Neonate 2005 88 : 54 6.
11. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 2006 118 : e1019 26.
12. Lehrnbecher T, Groll AH. Experiences with the use of caspofungin in paediatric patients. Mycoses 2008 51 (Suppl 1 58 64.